Protocol for producing an adeno-associated virus vector by controlling capsid expression timing
- PMID: 38103199
- PMCID: PMC10751547
- DOI: 10.1016/j.xpro.2023.102542
Protocol for producing an adeno-associated virus vector by controlling capsid expression timing
Abstract
Conventional adeno-associated virus (AAV) production systems generate vast numbers of empty capsids, which should be eliminated before clinical use. Here, we present a protocol for efficient AAV vector production. We describe steps for separating replicase and capsid genes from the plasmid and controlling capsid expression until sufficient AAV vector genome replication is achieved. This protocol can produce AAV vectors in various serotypes. For complete details on the use and execution of this protocol, please refer to Ohba et al.1.
Keywords: Cell Biology; Health Sciences; Microbiology.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests This work was partly funded by a Joint Research Fund sponsored by Takara Bio Inc. Based on the present study, K.O. and TAKARA Bio Inc. have applied for an international patent.
Figures



Similar articles
-
Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.J Virol. 2021 Sep 9;95(19):e0077321. doi: 10.1128/JVI.00773-21. Epub 2021 Jul 21. J Virol. 2021. PMID: 34287038 Free PMC article.
-
Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.J Virol. 2017 Sep 27;91(20):e01198-17. doi: 10.1128/JVI.01198-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768875 Free PMC article.
-
Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.J Virol. 2017 Jan 18;91(3):e01980-16. doi: 10.1128/JVI.01980-16. Print 2017 Feb 1. J Virol. 2017. PMID: 27852862 Free PMC article.
-
Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.Hum Gene Ther. 2015 Dec;26(12):786-800. doi: 10.1089/hum.2015.107. Epub 2015 Oct 15. Hum Gene Ther. 2015. PMID: 26414293 Free PMC article. Review.
-
Recent Advances in the Analysis Full/Empty Capsid Ratio and Genome Integrity of Adeno-associated Virus (AAV) Gene Delivery Vectors.Curr Mol Med. 2020;20(10):806-813. doi: 10.2174/1566524020999200730181042. Curr Mol Med. 2020. PMID: 32748744 Review.
Cited by
-
Development and Validation of AAV-Mediated Liver, Liver-VAT, and Liver-Brain SORT and Therapeutic Regulation of FASN in Hepatic De Novo Lipogenesis.Cells. 2025 Mar 4;14(5):372. doi: 10.3390/cells14050372. Cells. 2025. PMID: 40072100 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials